We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Preconception Trace Metal Profiles in Couples: A New Frontier in Optimizing IVF Embryological Outcomes

MedXY Editorial Team•Dec 27, 2025•news
IVFreproductive healthTrace elements

Highlights of the Research

The study demonstrates that preconception plasma trace metal levels in both partners significantly influence early IVF embryological outcomes. Key findings include:

  • High exposure to trace metal mixtures in couples and male partners is associated with a decrease in best-quality embryos and blastocyst numbers.
  • Specific individual elements show divergent effects: Iron (Fe), Lithium (Li), Strontium (Sr), and Molybdenum (Mo) are positively associated with favorable embryological outcomes.
  • Conversely, Silver (Ag) and Thallium (Tl) were identified as harmful elements, negatively impacting fertilization and embryo development.
  • The study underscores the necessity of a couple-based approach, rather than focusing solely on maternal health, to optimize assisted reproductive technology (ART) success.
MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Labour Progression Differences Between IVF/ICSI and Spontaneous Pregnancies Following Induction: Insights from a Matched Cohort StudyThis study reveals that nulliparous women with IVF/ICSI pregnancies experience slower labour progression and lower vaginal delivery rates after induction compared to spontaneous conceptions, with epidural analgesia impacting timing but notAug 18, 2026Early Life Adversity and Polycystic Ovary Syndrome among North American Pregnancy Planners: A Comprehensive ReviewThis review synthesizes current evidence linking adverse childhood experiences with increased risk and features of PCOS, highlighting possible neuroendocrine mechanisms and clinical implications for reproductive health management.Jul 1, 2026Tamoxifen and Uterine Disease Risk in Young Breast Cancer Survivors: Evidence from a Target Trial Emulation StudyA large-scale cohort study of premenopausal women demonstrates that adjuvant tamoxifen significantly increases the risk of endometrial cancer, hyperplasia, and polyps, with risk correlating to treatment duration.Mar 13, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Post-Dobbs Abortion Bans Linked to Significant Rise in Postpartum Depression Among Low-Socioeconomic Populations
A retrospective cohort study reveals that state-level abortion bans following the Dobbs decision significantly increased postpartum depression risk by 9% specifically among women in low-socioeconomic communities, highlighting a growing ment
Feb 6, 2026
Beyond the Incessant Ovulation Hypothesis: How Menopausal Status and Birth Cohort Reshape Ovarian Cancer RiskA massive cohort study of 2.2 million women reveals that ovarian cancer risk factors vary significantly by menopausal status and birth year. While early menarche and low parity remain universal risks, the protective benefits of breastfeedinFeb 6, 2026
Evidence-Based Evolution: How FDA Scientists Shielded Mifepristone Regulation From Political InterferenceA comprehensive review of over 5,000 FDA documents confirms that the agency’s regulation of mifepristone between 2011 and 2023 was driven by clinical safety data and internal scientific consensus, remaining remarkably resilient againsJan 17, 2026